Why use it

Dyspnea is one of the most distressing symptoms in seriously ill patients and is particularly under-recognized and under-treated in those who cannot self-report. Dyspnea affects 50–70% of patients with advanced cancer, 60–88% of patients with COPD, and is near-universal in the dying phase. The RDOS enables: (1) systematic identification of respiratory distress in non-verbal patients; (2) serial monitoring of response to dyspnea treatment (opioids, anxiolytics, positioning, oxygen); (3) objective documentation in medical records supporting clinical decisions; (4) triggering of palliative interventions before distress becomes severe. Without a structured observational tool, respiratory distress in non-verbal patients is frequently missed or undertreated.

About

The Respiratory Distress Observation Scale (RDOS) is a validated, nurse-administered observational instrument developed by Margaret Campbell and published in Heart & Lung in 2008 to measure the severity of respiratory distress in patients who are unable to self-report dyspnea — including intubated patients, patients with severe cognitive impairment, delirious or unconscious patients, and those near death. The RDOS emerged from Campbell's theoretical model of dyspnea as an asphyxial threat response — analogous to the FLACC scale for pain — and comprises eight observable indicators scored by a trained clinician during a brief bedside assessment: heart rate, respiratory rate, accessory muscle use, paradoxical breathing, restlessness, grunting at end-expiration, nasal flaring, and look of fear. Each item is scored 0–2 (0 = absent, 1 = mild, 2 = severe/present), yielding a total score of 0–16. Higher scores indicate greater respiratory distress. The RDOS was validated against patient self-report (Visual Analog Scale for dyspnea) in post-extubation patients (r = 0.68, p < 0.001) and demonstrated good inter-rater reliability (ICC 0.96). It is now widely used in palliative care, ICU, and end-of-life settings and is endorsed in multiple palliative care guidelines as the preferred tool for observational dyspnea assessment. A simplified 4-item version (sRDOS) has also been validated for rapid bedside screening.

When to use

Any patient who is unable to self-report dyspnea: intubated/mechanically ventilated, unconscious, severely delirious, or non-verbal
Palliative care patients in the dying phase — assess every 2–4 hours or with any sign of distress
ICU patients after extubation or ventilator weaning trials when self-report is unreliable
Patients with advanced dementia or severe cognitive impairment and suspected respiratory distress
Serial monitoring during palliative sedation titration to confirm symptom relief
End-of-life care in any setting (hospital, hospice, home, nursing home)
Benchmarking comfort care quality in palliative programs
NOT a substitute for patient self-report when patients CAN communicate — always ask first

Formula

RDOS = Sum of 8 observable items Total range: 0–16 Items and scoring: 1. Heart rate (bpm): <90 = 0 | 90–109 = 1 | ≥110 = 2 2. Respiratory rate (breaths/min): <19 = 0 | 19–30 = 1 | >30 = 2 3. Restlessness — non-purposeful movements: None = 0 | Occasional, slight = 1 | Frequent = 2 4. Paradoxical breathing — inward abdomen with inspiration: Absent = 0 | Present = 2 5. Accessory muscle use — neck/shoulder/intercostal: None = 0 | Slight = 1 | Pronounced = 2 6. Grunting at end-expiration — audible moaning: Absent = 0 | Present = 2 7. Nasal flaring — widening of nares with inspiration: Absent = 0 | Present = 2 8. Look of fear — wide eyes, furrowed brow, panicked expression: Absent = 0 | Present = 2 Distress Severity: 0–2: No distress 3–5: Mild distress 6–8: Moderate distress ≥9: Severe distress Target for palliative interventions: RDOS ≤3

Pearls & pitfalls

RDOS is observer-rated — the clinician watches the patient at rest for approximately 1 minute during normal care activities. Do not disturb the patient excessively; observe natural breathing pattern and behavior.
Grunting at end-expiration is highly specific for respiratory distress (rarely seen in comfortable patients) and carries the most clinical weight despite its 0 or 2 scoring — any grunting should prompt immediate assessment.
Paradoxical breathing (inward motion of the abdomen during inspiration, indicating diaphragm weakness or fatigue) is a critical safety indicator — it signals impending respiratory failure or extremely elevated work of breathing.
A "look of fear" is assessed as a global facial expression — wide eyes, furrowed brow, look of panic — not transient grimacing. This item requires clinical judgment and brief sustained observation.
Heart rate and respiratory rate contribute less to the total score than behavioral indicators — physiological parameters alone may be normal even when the patient has significant subjective distress.
In patients near death (actively dying), RDOS should be assessed every 2–4 hours or with any change in breathing pattern, position change, or caregiver concern.
The RDOS target for palliative care is RDOS ≤3 — scores above this threshold indicate meaningful distress requiring intervention.
Fan therapy (small electric fan directed at the patient's face) reduces dyspnea by stimulating trigeminal cold receptors — effective for mild distress and as an adjunct to pharmacological therapy.
Oxygen does NOT reliably reduce dyspnea in hypoxia-independent situations (e.g., lung cancer with normal SpO2) — treat dyspnea with opioids, not empirical oxygen, in advanced illness.
The RDOS has been validated across multiple clinical populations: cancer, COPD, heart failure, critically ill, and actively dying patients — it is not disease-specific.

Next steps

RDOS 0–2 (No distress): No respiratory distress detected. Continue monitoring every 2–4 hours. Maintain current care plan. RDOS 3–5 (Mild distress): Respiratory distress present. Reposition patient (head of bed 30–45°, lateral positioning). Provide fan airflow to face (reduces dyspnea via trigeminal nerve cooling). Review current analgesic and anxiolytic regimen. Consider low-dose morphine (2.5–5 mg SC/IV q4h) if opioid-naive or dose increase if already on opioids. Reassess in 30–60 minutes. RDOS 6–8 (Moderate distress): Initiate or escalate opioid therapy urgently. Morphine 5–10 mg SC/IV q4h ± 2.5 mg q1h PRN; or hydromorphone 1–2 mg SC/IV. Consider benzodiazepine if anxiety component (lorazepam 0.5–1 mg SC/IV/SL). Reassess every 30 minutes until controlled. RDOS ≥9 (Severe distress): Medical emergency in palliative care. Parenteral opioid bolus immediately (morphine 5–10 mg IV, repeat every 10–15 min until RDOS improves). Continuous subcutaneous or IV opioid infusion. Consider palliative sedation if symptoms are refractory to maximal analgesic therapy — consult palliative care team urgently.

Evidence

Campbell ML. Respiratory distress: a model of responses and behaviors to an asphyxial threat for patients who are unable to self-report. Heart Lung. 2008;37(1):54-60. PMID:18206527. Original instrument development and theoretical model. Campbell ML, Templin T, Walch J. A Respiratory Distress Observation Scale for patients unable to self-report dyspnea. J Palliat Med. 2010;13(3):285-290. PMID:20078242. Validation: r=0.68 vs VAS, ICC 0.96 inter-rater reliability. Campbell ML et al. Reliability and validity of a RDOS for non-verbal patients. J Palliat Med. 2019. n=236. Sensitivity 0.84, specificity 0.85 for detecting moderate-to-severe dyspnea at RDOS ≥3.

References

Campbell ML. Respiratory distress: a model of responses and behaviors to an asphyxial threat for patients unable to self-report. Heart Lung. 2008;37(1):54-60. — link
Campbell ML, Templin T, Walch J. A Respiratory Distress Observation Scale for patients unable to self-report dyspnea. J Palliat Med. 2010;13(3):285-290. — link
Campbell ML, Kiernan JM, Strandmark J, Yarandi HN. Trajectory of dyspnea and respiratory distress among patients in the last month of life. J Palliat Med. 2018;21(2):177-183. — link
Hui D, Maddocks M, Johnson MJ et al. Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines. ESMO Open. 2020;5(Suppl 1):e000984. — link
Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev. 2016;10:CD007354. — link

Respiratory Distress Observation Scale (RDOS)

Calculator